Latest News

Thursday, June 30, 2016 | Health Care, Prevent Blindness

Prevent Blindness to Hold 11th Annual Eyes on Capitol Hill Event

Prevent Blindness will be holding its 11th annual “Eyes on Capitol Hill” advocacy day on Tuesday, July 12, 2016, in Washington, D.C. Citizens from across the United States will have the op…

Read the full story

Thursday, June 30, 2016 | Product Releases, Oculus

Oculus Releases New Corvis ST Tonometer

The Oculus Corvis ST combines tonometry and pachymetry with the biomechanical response of the cornea in a new way. It is the first instrument enabling ophthalmologists to perform fast and comprehensiv…

Read the full story

Thursday, June 30, 2016 | Acquisitions/Mergers, OPKO Health

OPKO Health to Acquire Transition Therapeutics in Deal Valued at $60 Million

OPKO Health and Transition Therapeutics announced the signing of a definitive agreement under which OPKO will acquire Transition Therapeutics, a clinical stage biotechnology company. Under t…

Read the full story

Thursday, June 30, 2016 | Product Releases, CooperVision

CooperVision Unveils Biofinity Energys Contact Lenses Specifically Designed for Digital Device Users

CooperVision announced the introduction of Biofinity Energys with Digital Zone Optics lens design, pioneering contact lenses specifically created for digital device users. Combining breakthrough optic…

Read the full story

Thursday, June 30, 2016 | Clinical Trials, Shire

Shire Drug Candidate, SHP607, Does Not Meet Primary Endpoint of Reducing the Severity of ROP in Extremely Premature Infants; Reduces Other Morbidities

Shire announced that its phase 2 study evaluating an investigational protein replacement, SHP607, did not meet its primary endpoint of reducing the severity of retinopathy of prematurity (ROP), accord…

Read the full story

Wednesday, June 29, 2016 | FDA Approval/Clearance, ReVision Optics

ReVision Optics Receives FDA Approval for the Raindrop Near Vision Inlay

ReVision Optics received FDA approval for the Raindrop Near Vision Inlay, a novel corneal inlay for the surgical correction of presbyopia. The Raindrop Near Vision Inlay is indicated to improve near v…

Read the full story

Wednesday, June 29, 2016 | Partnerships, Essilor

Report: Improving the Vision of 2.5 Billion People Can Help Stimulate the Global Economy

Essilor has joined the EYElliance coalition and contributed to a new report published earlier this week by the World Economic Forum that highlights the strong case for investment in eyeglasses provisi…

Read the full story

Wednesday, June 29, 2016 | Cataract Surgery, Partnerships

Harman and HelpMeSee Reducing Blindness on a Global Scale

Harman announced its role in developing an enterprise software solution for simulation-based training management with HelpMeSee, the global campaign to end cataract blindness. This Training Management…

Read the full story

Wednesday, June 29, 2016 | CE Mark Approval, Product Releases

Eyenuk Announces CE Mark and Commercial Launch of EyeArt 2.0 Automated Diabetic Retinopathy Screening Software

Eyenuk announced receipt of the CE Mark and the launch of the second generation of its EyeArt fully automated diabetic retinopathy (DR) screening software. The company plans to roll out EyeArt 2.0 to …

Read the full story

Wednesday, June 29, 2016 | Product Releases, Compulink Business Systems

Compulink Showcases its OneTab EHR Technology at AOA’s Optometry’s Meeting 2016

Compulink Business Systems will demonstrate the latest enhancements to its Eyecare Advantage system at this year’s American Optometric Association’s annual meeting, according to a company …

Read the full story

Wednesday, June 29, 2016 | Conferences, Alcon Laboratories

Alcon showcases latest innovations at the 2016 Optometry’s Meeting

Alcon will preview DAILIES TOTAL1 Multifocal contact lenses, the first and only water gradient technology for patients with presbyopia, at this year’s Optometry’s Meeting. Attendees …

Read the full story

Tuesday, June 28, 2016 | Product Releases, Bio-Tissue

Bio-Tissue Announces Cliradex Light for the Treatment of Blepharitis Symptoms and for Daily Ocular Hygiene Use

Bio-Tissue announced the introduction of Cliradex Light, the newest addition to its Cliradex product line, a preservative-free, all-natural lid, lash and facial cleanser. Cliradex Light will be showca…

Read the full story

Tuesday, June 28, 2016 | Acquisitions/Mergers, Allergan

Mayne to Buy Generic Drugs From Allergan, Teva for $652 Million

Australia’s Mayne Pharma Group Ltd. agreed to buy a basket of generic drugs from Teva Pharmaceutical Industries Ltd. and Allergan Plc. for $652 million, as the two larger companies divest produc…

Read the full story

Tuesday, June 28, 2016 | Medical Studies

Technavio: Increased Cases of Eye Disorders to Create Opportunities for the Global Vision Care Market Through 2020

Technavio analysts forecast the global vision care market to exceed USD 61 billion by 2020, according to their latest report. The research study covers the present scenario and growth prospects of the…

Read the full story

Tuesday, June 28, 2016 | Product Releases, Management Plus

ManagementPlus to Launch Revenue Cycle Solutions (RCS) at Optometry Meetings

ManagementPlus announced that it will launch its Revenue Cycle Solutions (RCS) at the annual meeting of the American Optometric Association (AOA) and the American Optometric Student Association (AOSA)…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $17.60  0.00% 
 Akorn, Inc. $28.49  0.00% 
 Alimera Sciences, Inc. $1.23  0.00% 
 Allergan $231.09  0.00% 
 Avalanche Biotechnologies $4.14  0.00% 
 Bayer $100.65  0.00% 
 Can-Fite Biopharma $2.56  0.00% 
 Carl Zeiss Meditec $36.44  0.00% 
 Clearside Biomedical $7.01  0.00% 
 Cooper Companies, Inc. $171.57  0.00% 
 Eleven Biotherapeutics $1.67  0.00% 
 Escalon Medical Corp. $0.78  0.00% 
 Essilor International $118.85  0.00% 
 Glaukos $29.16  0.00% 
 Imprimis Pharmaceuticals, Inc. $3.76  0.00% 
 Inotek Pharmaceuticals $7.44  0.00% 
 IRIDEX Corporation $14.79  0.00% 
 Johnson & Johnson $121.30  0.00% 
 Luxottica Group, S.p.A. $48.86  0.00% 
 Merck & Company, Inc. $57.61  0.00% 
 NicOx $12.00  0.00% 
 NovaBay Pharmaceuticals, Inc. $2.50  0.00% 
 Novartis AG Common Stock $82.51  0.00% 
 Ocular Therapeutix $4.95  0.00% 
 Ophthotech Corporation $51.03  0.00% 
 QLT $1.42  0.00% 
 Quantel $3.42  0.00% 
 Regeneron $349.23  0.00% 
 Roche $32.95  0.00% 
 Second Sight Medical Products $3.58  0.00% 
 Shire $184.08  0.00% 
 STAAR Surgical Company $5.51  0.00% 
 TearLab Corporation $0.64  0.00% 
 Thrombogenics $3.20  0.00% 
 Valeant Pharmaceuticals $20.14  0.00% 
 Xoma $0.55  0.00%